About Pharos iBio

The Best Target & The Best Chemical

Leadership

Pharos iBio is working on new drug development by forming an organization with the best experts in each field, centered on CEO Yoon Jeong-hyuk (CEO), who has more than 25 years of protein structure analysis experience and more than 10 years of management know-how as a professional manager of a KOSDAQ listed company.

  • CEO Jeonghyeok Yoon
    • Ph.D. KAIST
    • KIST Post-Doc.
    • Senior Researcher at Mogam Institute
    • Technical Manager at Korea MSI
    • Research Director at IDR tech
    • CEO at EQUIS&ZAROO Co., Ltd(Listed KOSDAQ)
  • CDO June Hye-Jung Han
    • Researcher at SNU CRI
    • Ph.D. The University of Tokyo
    • Researcher at AGENE Inc.
    • Staff Scientist at Berkeley Lab
    • Researcher at UCSF
    • Senior researcher at Genentech
    • Principal Researcher at Roche
  • CBO Kyu-Tae Kim
    • Ph.D. Univ. of New South Wales
    • Manager at Green Cross Co.
    • Johns Hopkins Medical School Post-Doctoral Fellow
    • Lecturer of Univ. of Newcastle
    • CSO / BD&L Director of AbClon
  • CTO Ky-Youb Nam
    • Ph.D. Soongsil Univ.
    • Visiting Researcher of Univ. of Maryland Biotechnology Institute
    • Team Leader at Bioinformatics and Molecular Design Research Center
    • Academic committee at Korean Chemical Society
    • Head of R&D Center at EQUIS&ZAROO Co., Ltd
    • Planning Advisor of Korea MFDS
  • CSO Chong Chul Chai
    • Ph.D. KAIST
    • Bs. YONSEI Univ.
    • Principal Engineer at SAMSUNG Electronics
    • Principal Engineer at SAMSUNG Display
  • CFO Sungwon Mun
    • B.A Business Administration, Korea Univ.
    • Team leader at investment advisers
    • Managing Director at Vextone Asia Research
    • CEO at Purple Investment